Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Receivables (2020 - 2025)

Historic Receivables for NeuroPace (NPCE) over the last 6 years, with Q3 2025 value amounting to $14.9 million.

  • NeuroPace's Receivables rose 2921.03% to $14.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.9 million, marking a year-over-year increase of 2921.03%. This contributed to the annual value of $12.9 million for FY2024, which is 475.88% up from last year.
  • NeuroPace's Receivables amounted to $14.9 million in Q3 2025, which was up 2921.03% from $13.6 million recorded in Q2 2025.
  • In the past 5 years, NeuroPace's Receivables ranged from a high of $15.4 million in Q1 2025 and a low of $6.6 million during Q3 2021
  • For the 5-year period, NeuroPace's Receivables averaged around $10.4 million, with its median value being $10.9 million (2023).
  • Per our database at Business Quant, NeuroPace's Receivables crashed by 1558.33% in 2021 and then skyrocketed by 6458.17% in 2023.
  • NeuroPace's Receivables (Quarter) stood at $7.1 million in 2021, then grew by 5.51% to $7.5 million in 2022, then skyrocketed by 64.58% to $12.3 million in 2023, then increased by 4.36% to $12.9 million in 2024, then rose by 16.24% to $14.9 million in 2025.
  • Its last three reported values are $14.9 million in Q3 2025, $13.6 million for Q2 2025, and $15.4 million during Q1 2025.